Holen Sie sich die Stockscreener-App
9.63
1.90%
0.18
Schlusskurs vom Vortag:
$9.45
Offen:
$9.7
24-Stunden-Volumen:
1.03M
Relative Volume:
0.31
Marktkapitalisierung:
$682.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-5.1223
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
+17.15%
1M Leistung:
+27.55%
6M Leistung:
+204.75%
1J Leistung:
-20.74%
1-Tages-Spanne:
$9.50
$9.8399
1-Wochen-Bereich:
$8.04
$10.00
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
9.63 | 670.01M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Omeros (NASDAQ:OMER) Shares Pass Above 200 Day Moving AverageHere's Why - MarketBeat
Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid (NASDAQ:OMER) - Seeking Alpha
What technical signals suggest for Omeros Corporation stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com
Omeros Corporation Stock Analysis and ForecastInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Is Omeros Corporation stock cheap compared to fundamentalsIPO Watch & Technical Entry and Exit Tips - newser.com
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Omeros (NASDAQ:OMER) Shares Down 5.6%Should You Sell? - MarketBeat
Here's Why Shares in Theravance Biopharma Exploded Today - AOL.com
Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal - AOL.com
How strong is Omeros Corporation stock revenue growthBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why - AOL.com
Omeros (NASDAQ:OMER) Stock Price Up 8.1%Time to Buy? - MarketBeat
Omeros Corporation (NASDAQ:OMER) Q3 2025 Earnings Call Transcript - Insider Monkey
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - AOL.com
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - AOL.com
Omeros Corporation’s Earnings Call Highlights Strategic Moves - TipRanks
test-commerce-234 - AOL.com
Omeros (OMER) Q3 2025 Earnings Call Transcript - The Globe and Mail
Published on: 2025-11-17 02:29:02 - newser.com
Omeros Corporation stock outlook for YEARJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER) - MarketBeat
What candlestick patterns are forming on Omeros CorporationWeekly Stock Summary & Proven Capital Preservation Methods - newser.com
Omeros (NASDAQ:OMER) Shares Gap UpHere's Why - MarketBeat
Is Omeros Corporation meeting your algorithmic filter criteriaMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
Ranking Omeros Corporation among high performing stocks via toolsJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Omeros (NASDAQ:OMER) Cut to Sell at Wall Street Zen - MarketBeat
Omeros files automatic mixed securities shelf - MSN
Omeros (NASDAQ:OMER) Announces Quarterly Earnings Results - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Omeros (OMER) Receives Analyst 'Buy' Rating with Stable Price Ta - GuruFocus
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Omeros Sets Sights On Big Pharma Deal And FDA Green Light - Finimize
Omeros: Q3 Earnings Snapshot - CTPost
Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada
Can Omeros Corporation stock resist market sell offsOptions Play & Free Community Supported Trade Ideas - newser.com
Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
Omeros Corporation Reports Q3 2025 Financial Results - TipRanks
Omeros Inks Big Deal With Novo Nordisk And Eyes FDA Nod - Finimize
Applied Therapeutics, Omeros, And Others Post Sharp Moves After Market Close - Nasdaq
Omeros Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omeros Q3 2025 sees narrower loss, stock drops - Investing.com Nigeria
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):